Federal Court of Australia
FEDERAL COURT OF AUSTRALIA
Sanofi-Aventis Deutschland GmbH v Alphapharm Pty Ltd [2019] FCAFC 28 Appeal from: Sanofi-Aventis Deutschland GmbH v Alphapharm Pty Ltd (No 3) [2018] FCA 2060
File number: NSD 2398 of 2018
Judges: JAGOT, YATES AND MOSHINSKY JJ
Date of judgment: 22 February 2019
Catchwords: [PRACTICE AND PROCEDURE- patents – interlocutory injunction application – prima facie case – validity of patents – novelty – balance of convenience - leave to appeal dismissed.
Cases cited: GenRx Pty Ltd v Sanofi-Aventis [2007] FCA 148 House v The King (1936) 55 CLR 499 Interpharma Pty Ltd v Commissioner of Patents [[2008] FCA 1498 Janssen Sciences Ireland UC v Alphapharm Pty Ltd [2017] FCA 1399 Love v Thwaites & Anor (No 4) [2012] VSC 521 Love v Thwaites & Anor [2014] VSCA 56 Samsung Electronics Company Ltd v Apple Inc (2011) 217 FCR 238 Sanofi-Aventis Deutschland GmbH v Alphapharm Pty Ltd (No 3) [2018] FCA 2060 Warner-Lambert Co LLC v Apotex Pty Ltd [2014] FCAFC 59
Date of hearing: 8 February 2019
Registry: New South Wales
Division: General
National Practice Area: Intellectual Property
Sub-area: Patents and Associated Statutes
Category: Catchwords
Number of paragraphs: 54
Counsel for the Applicants: C Dimitriadis SC with A R Lang
Solicitor for Applicants: Jones Day
Counsel for the Respondent: T D Cordiner QC with J S Cooke
We try to embed the page this law was scraped from. If the site blocks framing, you still get the link and a local excerpt.
Last checked with source on —
Checking whether the official page can be embedded…
Plain-English simplify of this law: a short summary, key points, and both sides of the argument. Generated on first view via Replicate, then cached. Vote on what helps your study.
No study brief is cached for this law yet. Sign up to generate a plain-English brief.
Sign up to generate